During the past decade, Braverman-Terry-Oei Eye Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Braverman-Terry-Oei Eye Associates" are "Presbyopia" (3 trials) and "Cataract" (1 trials). Many other conditions were trialed in "Braverman-Terry-Oei Eye Associates" in a lesser frequency.

Most popular intervention types in "Braverman-Terry-Oei Eye Associates" are "Device" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clobetasol Propionate" (1 trials), "PresVIEW Scleral Implants" (1 trials), "Vehicle" (1 trials), "VisAbility Micro Insert" (1 trials) and "VisAbility™ Micro Insert" (1 trials). Other intervention names were less common.

The vast majority of trials in "Braverman-Terry-Oei Eye Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Braverman-Terry-Oei Eye Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Braverman-Terry-Oei Eye Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Braverman-Terry-Oei Eye Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".